Dwight E. Heron
Experienced in Laryngeal Cancer

Dr. Dwight E. Heron

Radiation Oncology
Mercy Health
Mercy Health — St. Elizabeth Youngstown Radiation Oncology
1044 Belmont Avenue, 
Youngstown, OH 
On Staff At
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Experienced in Laryngeal Cancer
Mercy Health
Mercy Health — St. Elizabeth Youngstown Radiation Oncology
1044 Belmont Avenue, 
Youngstown, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dwight Heron is a Radiation Oncologist in Youngstown, Ohio. Dr. Heron is rated as an Experienced provider by MediFind in the treatment of Laryngeal Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Prostate Cancer, Lung Cancer, Pancreaticoduodenectomy, and Prostatectomy. Dr. Heron is currently accepting new patients.

His clinical research consists of co-authoring 183 peer reviewed articles and participating in 20 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Laryngeal Cancer.

Graduate Institution
University Of Rochester School Of Medicine/Dentistry, 1995
Residency
Thomas Jefferson University Hospital, Radiation Oncology, 2000
Specialties
Radiation Oncology
Licenses
Radiology in PA
Board Certifications
American Board Of Radiology
Hospital Affiliations
Mercy Health - St. Joseph Warren Hospital
Mercy Health - St. Elizabeth Youngstown Hospital
Mercy Health - St. Elizabeth Boardman Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AultCare
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
SummaCare
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Mercy Health — St. Elizabeth Youngstown Radiation Oncology
1044 Belmont Avenue, Youngstown, OH 44504
Call: 330-480-2182
Other Locations
Mercy Health — Boardman Medical Oncology
8401 Market Street, Boardman, OH 44512
Call: 330-729-7530
Mercy Health — St. Joseph Warren Radiation Oncology
667 Eastland Avenue Southeast, Warren, OH 44484
Call: 330-841-4126

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

20 Clinical Trials

Autologous Stem Cell Transplantation With CD34-Selected Peripheral Blood Stem Cells (PBSC) in Patients With Treatment Resistant Systemic Sclerosis (SSc)
Autologous Stem Cell Transplantation With CD34-Selected Peripheral Blood Stem Cells (PBSC) in Patients With Treatment Resistant Systemic Sclerosis (SSc)
Enrollment Status: Recruiting
Publish Date: October 15, 2025
Intervention Type: Drug, Radiation
Study Drugs: Cyclophosphamide, Mesna, Rituximab, Alemtuzumab, Thiotepa, GM-CSF, Intravenous immunoglobulin
Study Phase: Phase 2
A Randomized, Phase II Study of Definitive Radiotherapy With Concurrent Cisplatin vs. Docetaxel-cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma: an ERCC1 Biomarker Enrichment and Interaction Design
A Randomized, Phase II Study of Definitive Radiotherapy With Concurrent Cisplatin vs. Docetaxel-cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma: an ERCC1 Biomarker Enrichment and Interaction Design
Enrollment Status: Recruiting
Publish Date: March 26, 2025
Intervention Type: Drug, Radiation
Study Drugs: Cisplatin, Docetaxel, Cetuximab
Study Phase: Phase 2
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Completed
Publish Date: January 14, 2026
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 2/Phase 3
Utilization of Low Level Laser Therapy for Radiation Induced Dermatitis in Patients With Head and Neck Squamous Cell Carcinoma
Utilization of Low Level Laser Therapy for Radiation Induced Dermatitis in Patients With Head and Neck Squamous Cell Carcinoma
Enrollment Status: Completed
Publish Date: June 27, 2025
Intervention Type: Device
Study Phase: Not Applicable
Phase II Study Determining the Efficacy of Pre-operative Stereotactic Radiosurgery Followed by Resection for Brain Metastases
Phase II Study Determining the Efficacy of Pre-operative Stereotactic Radiosurgery Followed by Resection for Brain Metastases
Enrollment Status: Completed
Publish Date: June 26, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
PHASE I STUDY OF FRACTIONATED STEREOTACTIC RADIOSURGERY FOR LARGE BRAIN METASTASES
PHASE I STUDY OF FRACTIONATED STEREOTACTIC RADIOSURGERY FOR LARGE BRAIN METASTASES
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
A Phase I Study of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases
A Phase I Study of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases
Enrollment Status: Completed
Publish Date: October 10, 2024
Intervention Type: Radiation
Study Phase: Not Applicable
Prospective Evaluation Of Hypofractionated Stereotactic Body Radiotherapy For Low And Intermediate Risk Prostate Cancer
Prospective Evaluation Of Hypofractionated Stereotactic Body Radiotherapy For Low And Intermediate Risk Prostate Cancer
Enrollment Status: Completed
Publish Date: May 02, 2024
Intervention Type: Radiation
Study Phase: Not Applicable
Phase II Study for Curative Intent Treatment for Patients With Oligometastatic Disease at Initial Presentation
Phase II Study for Curative Intent Treatment for Patients With Oligometastatic Disease at Initial Presentation
Enrollment Status: Terminated
Publish Date: October 11, 2023
Intervention Type: Radiation, Drug
Study Phase: Phase 2
Randomized Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Randomized Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Enrollment Status: Completed
Publish Date: June 05, 2023
Intervention Type: Drug, Radiation
Study Drugs: Cetuximab, Docetaxel
Study Phase: Phase 2
Phase II Study of Stereotactic Radiosurgery for Patients With Oligo-recurrent Disease
Phase II Study of Stereotactic Radiosurgery for Patients With Oligo-recurrent Disease
Enrollment Status: Completed
Publish Date: May 19, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Other, Drug, Radiation
Study Drugs: Carboplatin, Cisplatin, Paclitaxel
Study Phase: Phase 3
A Phase II Prospective Trial of Low-Level Laser Therapy for Prevention of Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer
A Phase II Prospective Trial of Low-Level Laser Therapy for Prevention of Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer
Enrollment Status: Completed
Publish Date: April 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
Induction Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma A Prospective Evaluation in Patients With Locally Advanced Pancreas Cancer
Induction Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma A Prospective Evaluation in Patients With Locally Advanced Pancreas Cancer
Enrollment Status: Completed
Publish Date: March 08, 2022
Intervention Type: Drug, Radiation
Study Phase: Phase 2
Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck
Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Device, Drug
Study Drug: Cetuximab
Study Phase: Phase 2
A Prospective, Randomized Phase II Study of Surgery With or Without Adjuvant Stereotactic Body Radiotherapy (SBRT) in Patients With Previously-Irradiated Head and Neck Cancer
A Prospective, Randomized Phase II Study of Surgery With or Without Adjuvant Stereotactic Body Radiotherapy (SBRT) in Patients With Previously-Irradiated Head and Neck Cancer
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Radiation
Study Phase: Not Applicable
SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma A Prospective Evaluation in Select Patients With Resected Pancreas Cancer
SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma A Prospective Evaluation in Select Patients With Resected Pancreas Cancer
Enrollment Status: Completed
Publish Date: November 24, 2021
Intervention Type: Radiation
Study Phase: Not Applicable
Chemotherapy (Paclitaxel and Carboplatin)and Thoracic Radiotherapy With Swallowed Manganese Superoxide Dismutase (MnSOD) Plasmid Liposome Protection in Patients With Locally Advanced Stage III Non-Small Cell Lung Cancer: A Phase I-II Study
Chemotherapy (Paclitaxel and Carboplatin)and Thoracic Radiotherapy With Swallowed Manganese Superoxide Dismutase (MnSOD) Plasmid Liposome Protection in Patients With Locally Advanced Stage III Non-Small Cell Lung Cancer: A Phase I-II Study
Enrollment Status: Terminated
Publish Date: November 12, 2021
Intervention Type: Drug, Genetic, Radiation
Study Phase: Phase 1/Phase 2
Measuring the Effect of Radiation Therapy on Patient Activity Levels
Measuring the Effect of Radiation Therapy on Patient Activity Levels
Enrollment Status: Terminated
Publish Date: August 09, 2018
View 18 Less Clinical Trials

187 Total Publications

Recurrent Squamous Cell Carcinoma of the Head & Neck: Novel Approaches to Re-Irradiation.
Recurrent Squamous Cell Carcinoma of the Head & Neck: Novel Approaches to Re-Irradiation.
Journal: Otolaryngologic clinics of North America
Published: September 30, 2025
View All 187 Publications
Similar Doctors
Distinguished in Laryngeal Cancer
Dr. Neil Woody
Radiation Oncology
Distinguished in Laryngeal Cancer
Dr. Neil Woody
Radiation Oncology

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
 (51.7 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Neil Woody is a Radiation Oncologist in Cleveland, Ohio. Dr. Woody is rated as a Distinguished provider by MediFind in the treatment of Laryngeal Cancer. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Teratocarcinosarcoma, Head and Neck Squamous Cell Carcinoma (HNSCC), and Thyroidectomy.

Distinguished in Laryngeal Cancer
Dr. Anand B. Desai
Radiation Oncology
Distinguished in Laryngeal Cancer
Dr. Anand B. Desai
Radiation Oncology

Summa Physicians LLC

525 E Market St, 
Akron, OH 
 (37.4 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Anand Desai is a Radiation Oncologist in Akron, Ohio. Dr. Desai is rated as an Advanced provider by MediFind in the treatment of Laryngeal Cancer. His top areas of expertise are Posterior Fossa Tumor, Laryngeal Cancer, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Desai is currently accepting new patients.

Edward Walsh
Distinguished in Laryngeal Cancer
Dr. Edward Walsh
Radiation Oncology
Distinguished in Laryngeal Cancer
Dr. Edward Walsh
Radiation Oncology

Cleveland Clinic Mercy Hospital

1320 Mercy Drive NW, 
Canton, OH 
 (39.3 miles away)
Languages Spoken:
English
See accepted insurances

Edward Walsh is a Radiation Oncologist in Canton, Ohio. Dr. Walsh is rated as an Advanced provider by MediFind in the treatment of Laryngeal Cancer. His top areas of expertise are Mediastinal Tumor, Familial Prostate Cancer, Laryngeal Cancer, and Pleuropulmonary Blastoma.

VIEW MORE LARYNGEAL CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Heron's expertise for a condition
ConditionClose
    • Distinguished
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
      Dr. Heron is
      Distinguished
      . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
      See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
    • Advanced
    • Familial Prostate Cancer
      Dr. Heron is
      Advanced
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    • Lung Cancer
      Dr. Heron is
      Advanced
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Prostate Cancer
      Dr. Heron is
      Advanced
      . Learn about Prostate Cancer.
      See more Prostate Cancer experts
    • Experienced
    • Acoustic Neuroma
      Dr. Heron is
      Experienced
      . Learn about Acoustic Neuroma.
      See more Acoustic Neuroma experts
    • Anal Cancer
      Dr. Heron is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Bone Tumor
      Dr. Heron is
      Experienced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    • Brain Tumor
      Dr. Heron is
      Experienced
      . Learn about Brain Tumor.
      See more Brain Tumor experts
    • Breast Cancer
      Dr. Heron is
      Experienced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Breast Cancer in Men
      Dr. Heron is
      Experienced
      . Learn about Breast Cancer in Men.
      See more Breast Cancer in Men experts
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.